RUBINSTEIN JULIE — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

RUBINSTEIN JULIE has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $13.37M.

Profile

RUBINSTEIN JULIE

Julie Rubinstein is an accomplished executive in the biotechnology industry, currently serving as the President and Chief Operating Officer (COO) of Adaptive Biotechnologies Corp. She has played a significant role in advancing the company's mission to harness the adaptive immune system to transform the diagnosis and treatment of disease. With extensive experience in leadership and operational roles, Rubinstein has contributed to the growth and strategic direction of the company.

RolePresident and COO
Notability75/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-04-29ADPTAdaptive Biotechnologies CorpS — Open-market sale19.0K$14.23$271K
2026-04-29ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$124K
2026-04-24ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.02$267K
2026-04-24ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-24ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$13.74$262K
2026-04-24ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-24ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.13$269K
2026-04-24ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-21ADPTAdaptive Biotechnologies CorpS — Open-market sale30.9K$14.66$454K
2026-04-21ADPTAdaptive Biotechnologies CorpM — Option exercise11.9K$12.14$144K
2026-04-21ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-21ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.55$277K
2026-04-21ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-21ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.57$278K
2026-04-21ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-16ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.18$270K
2026-04-16ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-16ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.61$278K
2026-04-16ADPTAdaptive Biotechnologies CorpM — Option exercise14.7K$8.46$125K
2026-04-16ADPTAdaptive Biotechnologies CorpS — Open-market sale19.1K$14.56$278K

Companies — Last 90 Days

Frequently Asked Questions

Who is RUBINSTEIN JULIE?

Julie Rubinstein is an accomplished executive in the biotechnology industry, currently serving as the President and Chief Operating Officer (COO) of Adaptive Biotechnologies Corp. She has played a significant role in advancing the company's mission to harness the adaptive immune system to transform the diagnosis and treatment of disease. With extensive experience in leadership …

How many SEC Form 4 filings has RUBINSTEIN JULIE submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has RUBINSTEIN JULIE been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 47 open-market sales ($13.37M) across all tracked filings.

Where can I see all of RUBINSTEIN JULIE's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live RUBINSTEIN JULIE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.